GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NGL Fine-Chem Ltd (NSE:NGLFINE) » Definitions » PEG Ratio

NGL Fine-Chem (NSE:NGLFINE) PEG Ratio : 1.48 (As of Mar. 28, 2025)


View and export this data going back to 2022. Start your Free Trial

What is NGL Fine-Chem PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, NGL Fine-Chem's PE Ratio without NRI is 21.47. NGL Fine-Chem's 5-Year EBITDA growth rate is 14.50%. Therefore, NGL Fine-Chem's PEG Ratio for today is 1.48.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for NGL Fine-Chem's PEG Ratio or its related term are showing as below:

NSE:NGLFINE' s PEG Ratio Range Over the Past 10 Years
Min: 0.2   Med: 0.93   Max: 4.43
Current: 1.5


During the past 13 years, NGL Fine-Chem's highest PEG Ratio was 4.43. The lowest was 0.20. And the median was 0.93.


NSE:NGLFINE's PEG Ratio is ranked better than
54.4% of 364 companies
in the Drug Manufacturers industry
Industry Median: 1.695 vs NSE:NGLFINE: 1.50

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


NGL Fine-Chem PEG Ratio Historical Data

The historical data trend for NGL Fine-Chem's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NGL Fine-Chem PEG Ratio Chart

NGL Fine-Chem Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.28 0.87 0.69 1.83 3.18

NGL Fine-Chem Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.90 3.18 3.16 2.87 4.25

Competitive Comparison of NGL Fine-Chem's PEG Ratio

For the Drug Manufacturers - General subindustry, NGL Fine-Chem's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NGL Fine-Chem's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's PEG Ratio distribution charts can be found below:

* The bar in red indicates where NGL Fine-Chem's PEG Ratio falls into.


;
;

NGL Fine-Chem PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

NGL Fine-Chem's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=21.466464569913/14.50
=1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


NGL Fine-Chem  (NSE:NGLFINE) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


NGL Fine-Chem PEG Ratio Related Terms

Thank you for viewing the detailed overview of NGL Fine-Chem's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NGL Fine-Chem Business Description

Traded in Other Exchanges
Address
301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. Its geographical segments include India, Europe, Asia Pacific, United States, and Rest of the world. The Group's business activities fall within a single business segment of pharmaceuticals.

NGL Fine-Chem Headlines

No Headlines